These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 28126851)
1. Functional Evaluation of a De Novo Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851 [TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology. Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420 [TBL] [Abstract][Full Text] [Related]
3. A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia. Gao K; Tankovic A; Zhang Y; Kusumoto H; Zhang J; Chen W; XiangWei W; Shaulsky GH; Hu C; Traynelis SF; Yuan H; Jiang Y PLoS One; 2017; 12(2):e0170818. PubMed ID: 28182669 [TBL] [Abstract][Full Text] [Related]
4. Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy. Yuan H; Hansen KB; Zhang J; Pierson TM; Markello TC; Fajardo KV; Holloman CM; Golas G; Adams DR; Boerkoel CF; Gahl WA; Traynelis SF Nat Commun; 2014; 5():3251. PubMed ID: 24504326 [TBL] [Abstract][Full Text] [Related]
5. Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy. Marwick KFM; Hansen KB; Skehel PA; Hardingham GE; Wyllie DJA J Physiol; 2019 Mar; 597(6):1691-1704. PubMed ID: 30604514 [TBL] [Abstract][Full Text] [Related]
6. Disruption of S2-M4 linker coupling reveals novel subunit-specific contributions to N-methyl-d-aspartate receptor function and ethanol sensitivity. Hughes BA; Woodward JJ Neuropharmacology; 2016 Jun; 105():96-105. PubMed ID: 26577016 [TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation. Venkateswaran S; Myers KA; Smith AC; Beaulieu CL; Schwartzentruber JA; ; Majewski J; Bulman D; Boycott KM; Dyment DA Epilepsia; 2014 Jul; 55(7):e75-9. PubMed ID: 24903190 [TBL] [Abstract][Full Text] [Related]
8. Opportunities for Precision Treatment of Han W; Yuan H; Allen JP; Kim S; Shaulsky GH; Perszyk RE; Traynelis SF; Myers SJ J Pharmacol Exp Ther; 2022 Apr; 381(1):54-66. PubMed ID: 35110392 [TBL] [Abstract][Full Text] [Related]
9. GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers. Li D; Yuan H; Ortiz-Gonzalez XR; Marsh ED; Tian L; McCormick EM; Kosobucki GJ; Chen W; Schulien AJ; Chiavacci R; Tankovic A; Naase C; Brueckner F; von Stülpnagel-Steinbeis C; Hu C; Kusumoto H; Hedrich UB; Elsen G; Hörtnagel K; Aizenman E; Lemke JR; Hakonarson H; Traynelis SF; Falk MJ Am J Hum Genet; 2016 Oct; 99(4):802-816. PubMed ID: 27616483 [TBL] [Abstract][Full Text] [Related]
10. A structurally derived model of subunit-dependent NMDA receptor function. Gibb AJ; Ogden KK; McDaniel MJ; Vance KM; Kell SA; Butch C; Burger P; Liotta DC; Traynelis SF J Physiol; 2018 Sep; 596(17):4057-4089. PubMed ID: 29917241 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains. Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871 [TBL] [Abstract][Full Text] [Related]
16. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors. Kolcheva M; Kortus S; Krausova BH; Barackova P; Misiachna A; Danacikova S; Kaniakova M; Hemelikova K; Hotovec M; Rehakova K; Horak M Neuropharmacology; 2021 May; 189():108528. PubMed ID: 33773999 [TBL] [Abstract][Full Text] [Related]